Psychiatry & Neurology Doctors in Old Lyme, CT Accepting Medicare

3 Psychiatry & Neurology doctors found. Showing 1 - 3

Olaf Johan Ogland, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 19 Halls Rd, Old Lyme, CT 06371 Phone: 860-434-9400

Shragit Glazman, MD Psychiatry & Neurology - Geriatric Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 55 Hatchetts Hill Rd, Old Lyme, CT 06371 Phone: 800-370-3651

Joyce A Tinsley, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 7 Wolcott Ln, Old Lyme, CT 06371 Phone: 813-397-8313

News Archive

Schering-Plough commits to chronic hepatitis C research

Schering-Plough has reaffirmed its commitment to advancing the science and treatment of chronic hepatitis C virus (HCV) infection with several key data presentations at the European Association for the Study of the Liver (EASL) 42nd annual meeting in Barcelona, Spain, April 11-15.

Karger publishes new clinical guide on management of chronic itch

Although it is such a common symptom in dermatology, internal medicine, psychosomatics, neurology, and even oncology, itching was under-researched up until 15 years ago. Since then, the clinical aspects of acute and chronic itch have been examined extensively. A new clinical guide on how to manage itch has just been published by Karger.

SWHR co-sponsor Congressional briefing to explore impact of biological sex differences on biomedical research

The Endocrine Society and Society for Women's Health Research (SWHR) are co-sponsoring a Congressional briefing on July 10 to examine the need to include more female subjects in preclinical and clinical biomedical research - a move that could revolutionize medical research and scientific discovery.

BioDiem signs agreement with RMIT to create new non-influenza vaccines

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced that BioDiem has signed an agreement with The Royal Melbourne Institute of Technology (RMIT) regarding a research program that will investigate the use of BioDiem's live attenuated influenza virus (LAIV) to create new non-influenza vaccines. Developing the potential of the LAIV technology for new indications is an important part of BioDiem's strategy, and this research is part of the work towards that goal.

Read more Medical News

› Verified 7 days ago